Drug Profile
Gemcitabine - Hospira
Alternative Names: Gemcitabine hydrochloride - HospiraLatest Information Update: 14 Jan 2022
Price :
$50
*
At a glance
- Originator Hospira
- Class Amines; Antineoplastics; Deoxyribonucleosides; Fluorinated hydrocarbons; Ketones; Pyrimidine nucleosides; Pyrimidines; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer
Most Recent Events
- 03 Sep 2015 Hospira has been acquired by Pfizer